Table 1.
Demographic and baseline characteristics
| Characteristic | Cyclosporine (n = 33) | Tacrolimus (n = 31) |
|---|---|---|
| Recipient age (year) ± SD | 48.3 ± 12.5 | 44.9 ± 12.5 |
| Recipient gender n male (%) | 26 (78.8) | 23 (76.4) |
| Recipient weight (kg) ± SD | 77.0 ± 16.9 | 75.3 ± 11.9 |
| Recipient height (m) ± SD | 1.74 ± 0.12 | 1.74 ± 0.09 |
| Primary disease (n, %) | ||
| Primary glomerular disease | 12 (36.4) | 12 (38.7) |
| Diabetic nephropathy | 2 (6.1) | 1 (3.2) |
| Hypertension | 5 (15.2) | 4 (12.9) |
| Hereditary disease | 4 (12.1) | 6 (19.4) |
| Congenital dysplasia/reflux | 3 (9.1) | 1 (3.2) |
| Aetiology uncertain, other | 7 (21.1) | 7 (22.6) |
| Donor age (year) ± SD | 44.0 ± 14.6 | 46.8 ± 13.3 |
| Donor gender n male (%) | 13 (39.4) | 19 (61.3) |
| Procedure (n, %) | ||
| Cadaveric, heart beating | 16 (48.6) | 13 (41.9) |
| Cadaveric, non heart beating | 7 (21.1) | 4 (12.9) |
| Living related | 6 (18.2) | 9 (29.0) |
| Living unrelated | 4 (12.1) | 5 (16.2) |
| Delayed graft function (n, %) | 9 (27.3) | 6 (19.3) |
| GFR (ml min−1) ± SD* | 62.5 ± 13.2 | 65.1 ± 4.0 |
*
= Nankivell formula.